Loraz and Acute bilateral obstructive uropathy - a phase IV clinical study of FDA data

Summary:

Acute bilateral obstructive uropathy is reported as a side effect among people who take Loraz (lorazepam), especially for people who are male, 60+ old, also take Folic Acid, and have Metastases to bone.

The phase IV clinical study analyzes which people have Acute bilateral obstructive uropathy when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.

What is Acute bilateral obstructive uropathy?

Acute bilateral obstructive uropathy (sudden blockage of the flow of urine from both kidneys) is found to be associated with 130 drugs and 408 conditions by eHealthMe. Check the latest studies of Acute bilateral obstructive uropathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

161,700 people reported to have side effects when taking Loraz.
Among them, 22 people (0.01%) have Acute bilateral obstructive uropathy.

Could Loraz cause Acute bilateral obstructive uropathy?

Among these 22 people:

What is the gender of people who have Acute bilateral obstructive uropathy when taking Loraz? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Acute bilateral obstructive uropathy when taking Loraz? *

What are other drugs people take besides Loraz? *

Folic Acid: 20 people, 90.91%
Cephalexin: 19 people, 86.36%
Zometa: 19 people, 86.36%
Protonix: 19 people, 86.36%
Aranesp: 18 people, 81.82%
Dexamethasone: 18 people, 81.82%
Chlorhexidine Gluconate: 17 people, 77.27%
Fluconazole: 16 people, 72.73%
Zovirax: 16 people, 72.73%
Levaquin: 10 people, 45.45%

What are other side effects people have besides Acute bilateral obstructive uropathy? *

Abdominal Pain: 21 people, 95.45%
Haematuria (presence of blood in urine): 21 people, 95.45%
Anaemia (lack of blood): 20 people, 90.91%
Joint Pain: 20 people, 90.91%
Nausea And Vomiting: 20 people, 90.91%
Pain: 20 people, 90.91%
Acute Kidney Failure: 19 people, 86.36%
Injury: 19 people, 86.36%
Atelectasis (partial or complete collapse of the lung): 19 people, 86.36%
Osteonecrosis Of Jaw (death of bone of jaw): 19 people, 86.36%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 10 people, 45.45%
Multiple Myeloma (cancer of the plasma cells): 9 people, 40.91%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.55%
Cardiac Failure Congestive: 1 person, 4.55%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 1 person, 4.55%
Allergic Rhinitis: 1 person, 4.55%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.55%
Back Pain: 1 person, 4.55%
Bladder Cancer: 1 person, 4.55%
Enlarged Prostate: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and have Acute bilateral obstructive uropathy?

- Check whether Acute bilateral obstructive uropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loraz:

Loraz (165,695 reports)

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute bilateral obstructive uropathy:

Acute bilateral obstructive uropathy (130 drugs)

Browse all the conditions that are associated with Acute bilateral obstructive uropathy:

Acute bilateral obstructive uropathy (408 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.